BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37969088)

  • 21. Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome.
    Schneppenheim R; Frühwald MC; Gesk S; Hasselblatt M; Jeibmann A; Kordes U; Kreuz M; Leuschner I; Martin Subero JI; Obser T; Oyen F; Vater I; Siebert R
    Am J Hum Genet; 2010 Feb; 86(2):279-84. PubMed ID: 20137775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional relevance of genes predicted to be affected by epigenetic alterations in atypical teratoid/rhabdoid tumors.
    Tegeder I; Thiel K; Erkek S; Johann PD; Berlandi J; Thatikonda V; Frühwald MC; Kool M; Jeibmann A; Hasselblatt M
    J Neurooncol; 2019 Jan; 141(1):43-55. PubMed ID: 30446899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: SWI/SNF-deficient Sinonasal Neoplasms: An Overview.
    Agaimy A
    Head Neck Pathol; 2022 Mar; 16(1):168-178. PubMed ID: 35307773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secondary INI1-deficient rhabdoid tumors of the central nervous system: analysis of four cases and literature review.
    Nobusawa S; Nakata S; Yoshida Y; Yamazaki T; Ueki K; Amano K; Yamamoto J; Miyahara M; Sugai T; Nakazato Y; Hirato J; Yokoo H
    Virchows Arch; 2020 May; 476(5):763-772. PubMed ID: 31707588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The SWI/SNF chromatin-remodeling complex status in renal cell carcinomas with sarcomatoid or rhabdoid features.
    Kinoshita F; Kohashi K; Sugimoto M; Takamatsu D; Kiyozawa D; Eto M; Oda Y
    Virchows Arch; 2020 Nov; 477(5):651-660. PubMed ID: 32447490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent co-inactivation of the SWI/SNF subunits SMARCB1, SMARCA2 and PBRM1 in malignant rhabdoid tumours.
    Rao Q; Xia QY; Wang ZY; Li L; Shen Q; Shi SS; Wang X; Liu B; Wang YF; Shi QL; Ma HH; Lu ZF; He Y; Zhang RS; Yu B; Zhou XJ
    Histopathology; 2015 Jul; 67(1):121-9. PubMed ID: 25496315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SWI/SNF-deficient undifferentiated malignancies: where to draw the line
    Tessier-Cloutier B; Kleinman CL; Foulkes WD
    J Pathol; 2022 Feb; 256(2):139-142. PubMed ID: 34767264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rhabdoid tumors: integrating biological insights with clinical success: a report from the SMARCB1 and Rhabdoid Tumor Symposium, Paris, December 12-14, 2013.
    Bourdeaut F; Chi SN; Frühwald MC
    Cancer Genet; 2014 Sep; 207(9):346-51. PubMed ID: 25468731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on SWI/SNF-related gynecologic mesenchymal neoplasms: SMARCA4-deficient uterine sarcoma and SMARCB1-deficient vulvar neoplasms.
    Howitt BE; Folpe AL
    Genes Chromosomes Cancer; 2021 Mar; 60(3):190-209. PubMed ID: 33252159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rhabdoid tumors: clinical approaches and molecular targets for innovative therapy.
    Kerl K; Holsten T; Frühwald MC
    Pediatr Hematol Oncol; 2013 Oct; 30(7):587-604. PubMed ID: 23848359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth.
    Kim KH; Roberts CW
    Cancer Genet; 2014 Sep; 207(9):365-72. PubMed ID: 24853101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SWI/SNF protein expression status in fumarate hydratase-deficient renal cell carcinoma: immunohistochemical analysis of 32 tumors from 28 patients.
    Agaimy A; Amin MB; Gill AJ; Popp B; Reis A; Berney DM; Magi-Galluzzi C; Sibony M; Smith SC; Suster S; Trpkov K; Hes O; Hartmann A
    Hum Pathol; 2018 Jul; 77():139-146. PubMed ID: 29689242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Desmoplastic myxoid tumor, SMARCB1-mutant: a new variant of SMARCB1-deficient tumor of the central nervous system preferentially arising in the pineal region.
    Matsumura N; Goda N; Yashige K; Kitagawa M; Yamazaki T; Nobusawa S; Yokoo H
    Virchows Arch; 2021 Oct; 479(4):835-839. PubMed ID: 33420834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An infantile pineal embryonal tumor showing pathological features of a CNS ganglioneuroblastoma and the methylation profiling of an atypical teratoid/rhabdoid tumor and SMARCA4 mutation.
    Fukuoka K; Nakazawa A; Hirato J; Nobusawa S; Itabashi T; Arakawa Y; Mori M; Matsushita Y; Honda S; Tanami Y; Ichimura K; Kurihara J; Koh K
    J Neuropathol Exp Neurol; 2023 Jun; 82(7):664-667. PubMed ID: 37086056
    [No Abstract]   [Full Text] [Related]  

  • 35. [Chromatin remodeling defects and cancer: the SWI/SNF example].
    Bourdeaut F; Bièche I
    Bull Cancer; 2012 Dec; 99(12):1133-40. PubMed ID: 23222069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors.
    Pathak R; Zin F; Thomas C; Bens S; Gayden T; Karamchandani J; Dudley RW; Nemes K; Johann PD; Oyen F; Kordes U; Jabado N; Siebert R; Paulus W; Kool M; Frühwald MC; Albrecht S; Kalpana GV; Hasselblatt M
    Acta Neuropathol; 2021 Aug; 142(2):361-374. PubMed ID: 34003336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BRD9 defines a SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors.
    Wang X; Wang S; Troisi EC; Howard TP; Haswell JR; Wolf BK; Hawk WH; Ramos P; Oberlick EM; Tzvetkov EP; Ross A; Vazquez F; Hahn WC; Park PJ; Roberts CWM
    Nat Commun; 2019 Apr; 10(1):1881. PubMed ID: 31015438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Central nervous system atypical teratoid/rhabdoid tumor without loss of nuclear expression of INI1].
    Ryzhova MV; Kadyrov SU; Kumirova EV; Shishkina LV; Nikitin PV; Panina TN; Shibaeva IV; Shugay SV; Starovoytov DV; Sycheva RV; Zubova IV
    Arkh Patol; 2019; 81(2):36-42. PubMed ID: 31006778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome.
    Foulkes WD; Kamihara J; Evans DGR; Brugières L; Bourdeaut F; Molenaar JJ; Walsh MF; Brodeur GM; Diller L
    Clin Cancer Res; 2017 Jun; 23(12):e62-e67. PubMed ID: 28620006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SWI/SNF chromatin remodeling complexes and cancer.
    Biegel JA; Busse TM; Weissman BE
    Am J Med Genet C Semin Med Genet; 2014 Sep; 166C(3):350-66. PubMed ID: 25169151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.